David Manuel
Castro Díaz

Investigador en el periodo 1990-2024

Foto de David Manuel

Foto de University of Alberta

University of Alberta

Edmonton, Canadá

Publicaciones en colaboración con investigadores/as de University of Alberta (5)

2021

Corrigendum re “Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex” [Eur Urol Focus 2020;6:522–30] (European Urology Focus (2020) 6(3) (522–530), (S2405456919302962), (10.1016/j.euf.2019.09.020))
European Urology Focus

2018

6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE
Neurourology and Urodynamics

2016

Oral pharmacotherapy for overactive bladder in older patients: Mirabegron as a potential alternative to antimuscarinics
Current Medical Research and Opinion, Vol. 32, Núm. 4, pp. 621-638

2015

Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: Results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
Age and Ageing, Vol. 44, Núm. 5, pp. 745-755

2014

The efficacy and tolerability of the β3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients
Age and Ageing, Vol. 43, Núm. 5, pp. 666-675